"Vomiting" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The forcible expulsion of the contents of the STOMACH through the MOUTH.
| Descriptor ID |
D014839
|
| MeSH Number(s) |
C23.888.821.937
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Vomiting".
Below are MeSH descriptors whose meaning is more specific than "Vomiting".
This graph shows the total number of publications written about "Vomiting" by people in this website by year, and whether "Vomiting" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 1 | 2 |
| 1994 | 1 | 0 | 1 |
| 1995 | 2 | 2 | 4 |
| 1996 | 1 | 0 | 1 |
| 1997 | 7 | 2 | 9 |
| 1998 | 3 | 2 | 5 |
| 1999 | 2 | 1 | 3 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 3 | 3 |
| 2002 | 2 | 1 | 3 |
| 2003 | 1 | 0 | 1 |
| 2004 | 4 | 3 | 7 |
| 2005 | 4 | 4 | 8 |
| 2006 | 2 | 2 | 4 |
| 2007 | 5 | 2 | 7 |
| 2008 | 4 | 1 | 5 |
| 2009 | 5 | 5 | 10 |
| 2010 | 1 | 1 | 2 |
| 2011 | 1 | 4 | 5 |
| 2012 | 1 | 2 | 3 |
| 2013 | 5 | 1 | 6 |
| 2014 | 4 | 3 | 7 |
| 2015 | 9 | 2 | 11 |
| 2016 | 11 | 3 | 14 |
| 2017 | 0 | 4 | 4 |
| 2018 | 6 | 0 | 6 |
| 2019 | 2 | 6 | 8 |
| 2020 | 5 | 4 | 9 |
| 2021 | 3 | 1 | 4 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vomiting" by people in Profiles.
-
Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602). Oncologist. 2023 08 03; 28(8):722-729.
-
Single-dose NEPA versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy. Cancer Med. 2023 08; 12(15):15769-15776.
-
Real-World Treatment Outcomes, Healthcare Resource Use, and Costs Associated with Antiemetics Among Cancer Patients on Cisplatin-Based Chemotherapy. Adv Ther. 2023 Jul; 40(7):3217-3226.
-
Duration of Chemotherapy-Induced Nausea and Vomiting (CINV) as a Predictor of Recurrent CINV in Later Cycles. Oncologist. 2023 03 17; 28(3):208-213.
-
Clinical Manifestations and Stool Load of Atypical Enteropathogenic Escherichia coli Infections in United States Children and Adults. Gastroenterology. 2022 11; 163(5):1321-1333.
-
Olanzapine 5 mg vs 10 mg for the prophylaxis of chemotherapy-induced nausea and vomiting: a network meta-analysis. Support Care Cancer. 2022 Feb; 30(2):1015-1018.
-
Urinary Cannabis Metabolite Concentrations in Cannabis Hyperemesis Syndrome. J Pediatr Gastroenterol Nutr. 2021 10 01; 73(4):520-522.
-
Single-dose netupitant/palonosetron versus 3-day aprepitant for preventing chemotherapy-induced nausea and vomiting: a pooled analysis. Future Oncol. 2021 Aug; 17(23):3027-3035.
-
Cannabinoids and the Adolescent Patient: A Pragmatic Guide for Pediatric Practitioners. Pediatr Ann. 2021 Feb 01; 50(2):e57-e64.
-
Olanzapine for the prophylaxis and rescue of chemotherapy-induced nausea and vomiting: a systematic review, meta-analysis, cumulative meta-analysis and fragility assessment of the literature. Support Care Cancer. 2021 Jul; 29(7):3439-3459.